TP53 and B-cell chronic lymphocytic leukemia: Intriguingly, RelB has been shown to promote the growth of primary human fibroblast cells, and cells from chronic lymphocytic leukemia (CLL) patients, through regulating p53 stability, EZH2 expression and Rb activation [35].